C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease

Kidney International

Volumn 68, Issue 2, 2005, Pages 766-772

  Menon, Vandana ^b   Greene, Tom ^b   Wang, Xuelei ^b   Pereira, Arema A ^b   Marcovina, Santica M ^b   Beck, Gerald J ^b   Kusek, John W ^b   Collins, Alan J ^b   Levey, Andrew S ^b   Sarnak, Mark J ^a  

^a Division of Nephrology   (United States)

^b NONE

Author keywords

Albumin; C reactive protein; Chronic kidney disease; Inflammation; Outcomes

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; BIOLOGICAL MARKER; SERUM ALBUMIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HUMAN; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; STATISTICAL MODEL; SURVIVAL; ADOLESCENT; BLOOD; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIET THERAPY; METABOLISM; MIDDLE AGED; PREDICTION AND FORECASTING; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SERUM ALBUMIN;

EID: 26944473274     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00455.x     Document Type: Article

References (44)

1. ARICI M, WALLS J: End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link? Kidney Int 59:407-414, 2001
2. HERZIG KA, PURDIE DM, CHANG W, et al: Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients? J Am Soc Nephrol 12:814-821, 2001
3. ZIMMERMANN J, HERRLINGER S, PRUY A, et al: Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55:648-658, 1999
4. YEUN JY, LEVINE RA, MANTADILOK V, et al: C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 35:469-476, 2000
5. WANNER C, ZIMMERMANN J, SCHWEDLER S, et al: Inflammation and cardiovascular risk in dialysis patients. Kidney Int 61 (Suppl 80):99-102, 2002
6. CULLETON BF, LARSON MG, WILSON PW, et al: Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 56:2214-2219, 1999
7. FRIED LF, SHLIPAK MG, CRUMP C, et al: Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. J Am Coll Cardiol 41:1364-1372, 2003
8. MANJUNATH G, TIGHIOUART H, IBRAHIM H, et al: Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol 41:47-55, 2003
9. WEINER DE, TIGHIOUART H, AMIN MG, et al: Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: A pooled analysis of community-based studies. J Am Soc Nephrol 15:1307-1315, 2004
10. KNIGHT EL, RIMM EB, PAI JK, et al: Kidney dysfunction, inflammation, and coronary events: A prospective study. J Am Soc Nephrol 15:1897-1903, 2004
11. FOLEY RN, PARFREY PS, HARNETT JD, et al: Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. J Am Soc Nephrol 7:728-736, 1996
12. STENVINKEL P, HEIMBURGER O, PAULTRE F, et al: Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 55:1899-1911, 1999
13. MENON V, WANG X, GREENE T, et al: Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease. Am J Kidney Dis 42:44-52, 2003
14. KLAHR S, LEVEY AS, BECK GJ, et al: The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 330:877-884, 1994
15. GREENE T, BOURGOIGNIE JJ, HABWE V, et al: Baseline characteristics in the Modification of Diet in Renal Disease Study. J Am Soc Nephrol 4:1221-1236, 1993
16. PEARSON TA, MENSAH GA, ALEXANDER RW, et al: Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107:499-511, 2003
17. DRUEKE TB: Aspects of cardiovascular burden in pre-dialysis patients. Nephron 85 (Suppl 1):9-14, 2000
18. FOLEY RN, PARFREY PS, HARNETT JD, et al: Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 47:186-192, 1995
19. FOLEY RN, PARFREY PS, SARNAK MJ: Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 9:S16-S23, 1998
20. RIDKER PM, CUSHMAN M, STAMPFER MJ, et al: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336:973-979, 1997
21. TRACY RP, LEMAITRE RN, PSATY BM, et al: Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol 17:1121-1127, 1997
22. KULLER LH, TRACY RP, SHATEN J, et al: Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial. Am J Epidemiol 144:537-547, 1996
23. VARAGUNAM M, FINNEY H, TREVITT R, et al: Pretransplantation levels of C-reactive protein predict all-cause and cardiovascular mortality, but not graft outcome, in kidney transplant recipients. Am J Kidney Dis 43:502-507, 2004
24. NOH H, LEE SW, KANG SW, et al: Serum C-reactive protein: A predictor of mortality in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 18:387-394, 1998
25. DEFILIPPI C, WASSERMAN S, ROSANIO S, et al: Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis. JAMA 290:353-359, 2003
26. LIND L: Circulating markers of inflammation and atherosclerosis. Atherosclerosis 169:203-214, 2003
27. FORD ES: Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care 22:1971-1977, 1999
28. FOLSOM AR, PANKOW JS, TRACY RP, et al: Association of C-reactive protein with markers of prevalent atherosclerotic disease. Am J Cardiol 88:112-117, 2001
29. HAK AE, STEHOUWER CD, BOTS ML, et al: Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler Thromb Vasc Biol 19:1986-1991, 1999
30. MENDALL MA, PATEL P, BALLAM L, et al: C reactive protein and its relation to cardiovascular risk factors: A population based cross sectional study. BMJ 312:1061-1065, 1996
31. RIDKER PM, RIFAI N, ROSE L, et al: Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347:1557-1565, 2002
32. OWEN WF, LEW NL, LIU Y, et al: The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Eng J Med 329:1001-1006, 1993
33. ISEKI K, KAWAZOE N, FUKIYAMA K: Serum albumin is a strong predictor of death in chronic dialysis patients. Kidney Int 44:115-119, 1993
34. AVRAM MM, MITTMAN N, BONOMINI L, et al: Markers for survival in dialysis: A seven-year prospective study. Am J Kidney Dis 26:209-219, 1995
35. KALANTAR-ZADEH K, KOPPLE JD, BLOCK G, et al: A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis 38:1251-1263, 2001
36. OWEN WF, LOWRIE EG: C-reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int 54:627-636, 1998
37. COOPER BA, PENNE EL, BARTLETT LH, et al: Protein malnutrition and hypoalbuminemia as predictors of vascular events and mortality in ESRD. Am J Kidney Dis 43:61-66, 2004
38. KOPPLE JD, LEVEY AS, GREENE T, et al: Effect of dietary protein restriction on nutritional status in the Modification of Diet in Renal Disease Study. Kidney Int 52:778-791, 1997
39. ISEKI K, TOZAWA M, YOSHI S, et al: Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients. Nephrol Dial Transplant 14:1956-1960, 1999
40. DANESH J, WHEELER JG, HIRSCHFIELD GM, et al: C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350:1387-1397, 2004
41. ROST NS, WOLF PA, KASE CS, et al: Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: The Framingham study. Stroke 32:2575-2579, 2001
42. STRANDBERG TE, TILVIS RS: C-reactive protein, cardiovascular risk factors, and mortality in a prospective study in the elderly. Arterioscler Thromb Vasc Biol 20:1057-1060, 2000
43. LISSNER L, KARLSSON C, LINDROOS AK, et al: Birth weight, adulthood BMI, and subsequent weight gain in relation to leptin levels in Swedish women. Obes Res 7:150-154, 1999
44. MACY EM, HAYES TE, TRACY RP: Variability in the measurement of C-reactive protein in healthy subjects: Implications for reference intervals and epidemiological applications. Clin Chem 43:52-58, 1997